whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes

March 2008

A recent JAMA study has people asking whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes.

Acute coronary syndrome patients seem to have about twice the risk of death or heart attack within 90 days of stopping clopidogrel.

Researchers speculate it's a possible "rebound effect."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

more "pay for performance" programs to encourage providers to follow treatment guidelines
Diabetes whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients
Diabetes cinnamon DOESN'T lower blood glucose in diabetes patients
Hypertension Blood pressure is often measured wrong by patients
Cardiology whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes
Cardiology calcium MIGHT increase heart attack risk
Respiratory & Allergy neti pots or "nose bidets" for sinus problems, etc
Respiratory & Allergy Is Advair better than Spiriva for COPD
Women's Health whether caffeine increases the risk of miscarriage
Dermatology how to relieve dry skin
Supplements new focus on vitamin D deficiency
Neurology & Pain long-acting opioids more frequently than the preferred dosing schedule recommended by the manufacturer
Psychiatry FDA is warning about a possible increased risk of suicidal thoughts with antiepileptic drugs or Chantix (varenicline)